Nan van Geloven on Platelet Transfusion Outcomes in Preterm Infants With Severe Thrombocytopenia
Nan van Geloven, Assistant Professor at Leiden University Medical Center, reposted from JAMA on LinkedIn:
”NEW PAPER
“Regular predictions are not suited for supporting individual treatment decisions. Combining prediction with causal inference is needed instead.”
Telling is one thing, doing is another.
In this new JAMA paper we put our money where our mouth is and applied causal inference to develop and evaluate a prediction model that estimates risks under different treatment options, supporting treatment decisions in preterm infants.
Highly rewarding to get the chance to put our newly developed methods in action, together with a great team of clinicians and epidemiologists.”
JAMA shared on LinkedIn:
”Among preterm infants with severe thrombocytopenia, this modeling study found substantial variation among individuals in predicted benefits and harms of prophylactic platelet transfusion based on their current clinical characteristics.”
Read the full article in JAMA.
Article: Individualized Prediction of Platelet Transfusion Outcomes in Preterm Infants With Severe Thrombocytopenia
Authors: Hilde van der Staaij, Ilaria Prosepe, Camila Caram-Deelder, Ruth H. Keogh, Emöke Deschmann, Christof Dame, Wes Onland, Sandra A. Prins, Florian Cassel, Esther J. d’Haens, Elke van Westering-Kroon, Peter Andriessen, Sabine L. Vrancken, Christian V. Hulzebos, Daniel C. Vijlbrief, Suzanne F. Fustolo-Gunnink, Karin Fijnvandraat, Enrico Lopriore, Johanna G. van der Bom, Nan van Geloven

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 18, 2026, 01:45Shikha Jha: My Takeaways from the 4th GANSID International Congress
-
Nov 18, 2026, 01:34Zeeshan Ahmed Khattak: Treatment of Fever and Neutropenia in Hematology/Oncology and Hematopoietic Cell Transplant Patients
-
Nov 17, 2026, 23:45Cajetan Reichardt: LAAO vs. OAC in AF – Balancing Nonprocedural Bleeding and Ischemic Stroke Risk
-
Nov 17, 2026, 23:42Brian Tegtmeyer: Expanding Pre-Hospital Administration of Low-Titer O Positive Whole Blood
-
Nov 17, 2026, 23:41Mansi Kala: Advancing Hematology – From Evidence to Clinical Excellence
-
Nov 17, 2026, 23:40Nathan Connell: Registered for the WFH Comprehensive Care Summit 2027 in Prague
-
Nov 17, 2026, 23:38Yaariv Khaykin: Does Reducing AF Burden After Ablation Change the Need for Anticoagulation?
-
Nov 17, 2026, 23:38Amos Gitonga Mbaabu: Strengthening Care and Advocacy for Haemophilia and SCD across Southern Africa
-
Nov 17, 2026, 23:35Muhammad Sameed Altaf: A Decade of Working Together for Thalassemia Awareness and Patient Support